|
JPM26 is in SF on Jan 12-13 — get your spot No images? Click here The 1-on-1s: Nobel winner, VC bets, and pharma’s resetJANUARY 12 - 13, 2026 | 7:00 AM - 5:00 PM PT The executives steering biopharma through its toughest period are ready to share what they’re seeing. Mike Doustdar, CEO of Novo Nordisk, took the helm as the obesity market Novo pioneered became increasingly competitive. After several months leading the Danish giant, he's sitting down with Drew Armstrong to discuss his vision for reclaiming Novo's edge. Meanwhile, the dealmaking landscape is shifting in unexpected directions. Frank Jiang from Hengrui offers a rare window into how China's leading pharma views global partnerships after a year of landmark deals with Western companies. And bridging the gap between discovery and commercialization, Nobel laureate Fred Ramsdell connects cutting-edge science to commercial biotech.
AGENDA HIGHLIGHTS
Marianne De Backer JUST ADDED: In-person passes include access to our invite-only networking reception, featuring a live taping of Post-Hoc Live and special guest Noubar Afeyan, Founder and CEO of Flagship Pioneering. Coworking lounge, meeting space — your place at JPMThe Endpoints Hub offers a premium coworking lounge, a place to escape the noise, compare notes with peers who get it, and figure out your next move over breakfast, lunch, and real conversation. These conversations will set your agenda for navigating what's ahead. Join us.
Can't make it to SF? WHAT TO EXPECT AT ENDPOINTS AT JPM26?Real people, real conversations, real answers — get the full story from leaders on where we go from here.Candid discussions about what actually works when funding plateaus and barriers keep rising.The Endpoints Hub, a coworking space that offers sanctuary to meet, focus, and connect in the midst of the JPM frenzy.
EVENT SPONSORS |